932 - Cuts to mRNA Vaccine Development

932 - Cuts to mRNA Vaccine Development

Released Wednesday, 13th August 2025
Good episode? Give it some love!
932 - Cuts to mRNA Vaccine Development

932 - Cuts to mRNA Vaccine Development

932 - Cuts to mRNA Vaccine Development

932 - Cuts to mRNA Vaccine Development

Wednesday, 13th August 2025
Good episode? Give it some love!
Rate Episode
List

About this episode:

The Department of Health and Human Services has cancelled nearly $500 million in funding for the development of mRNA vaccines, including for vaccines against potential new pandemic threats. In this episode: Professor Bill Moss delves into the misinformation surrounding mRNA vaccines, explains their potential to treat diseases like cancer and HIV, and warns of the national security threats posed by cuts to development.

Guest:

Dr. Bill Moss, MPH, is an infectious disease specialist and the executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.

Host:

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.

Show links and related content:

Transcript information:

Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.

Contact us:

Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.

Follow us:

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Show More
Rate
List

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,